Article info
PDFReview
The role of the molecular footprint of EGFR in tailoring treatment decisions in NSCLC
- Correspondence to Professor Dr Kenneth O'Byrne, Hope Directorate, St James's Hospital, PO Box 580, James's Street, Dublin 8, Ireland; kobyrne{at}stjames.ie
Citation
The role of the molecular footprint of EGFR in tailoring treatment decisions in NSCLC
Publication history
- Accepted August 3, 2011
- First published October 29, 2011.
Online issue publication
December 13, 2011
Article Versions
- Previous version (29 October 2011).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
© 2011, Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions.